SEARCH

SEARCH BY CITATION

References

  • 1
    Berger J, Moser HW, Forss-Petter S. Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment. Curr Opin Neurol 2001;14:305312.
  • 2
    Kaye EM. Update on genetic disorders affecting white matter. Pediatr Neurol 2001;24:1124.
  • 3
    Raymond G, Eichler F, Fatemi A, Naidu S. Leukodystrophies. 1st ed. London: Mac Keith Press, 2011.
  • 4
    Bonkowsky JL, Nelson C, Kingston JL, et al. The burden of inherited leukodystrophies in children. Neurology 2010;75:718725.
  • 5
    Nelson C, Mundorff MB, Korgenski EK, et al. Determinants of health care use in a population-based leukodystrophy cohort. J Pediatr 2013;162:624628.
  • 6
    Krivit W, Aubourg P, Shapiro E, Peters C. Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 1999;6:377382.
  • 7
    Orchard PJ, Tolar J. Transplant outcomes in leukodystrophies. Semin Hematol 2010;47:7078.
  • 8
    de Ru MH, Boelens JJ, Das AM, et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 2011;6:55.
  • 9
    Brimley CJ, Lopez J, van Haren K, et al. National variation in costs and mortality for leukodystrophy patients in US children's hospitals. Pediatr Neurol 2013;49:156162.e1.
  • 10
    Norlin C, Osborn LM. Organizational responses to managed care: issues for academic health centers and implications for pediatric programs. Pediatrics 1998;101:805811.
  • 11
    Age distribution in Utah. Available at: http://governor.utah.gov/dea/Publications/05CensusBriefs2010/2AgeDistribution.pdf. Accessed 23 July 2013.
  • 12
    Lemoine TJ, Swoboda KJ, Bratton SL, et al. Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival? Pediatr Crit Care Med 2012;13:e161e165.
  • 13
    Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med 2011;183:14631471.
  • 14
    Gastmeier P, Geffers C. Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect 2006;64:326335.
  • 15
    Tenke P, Kovacs B, Bjerklund Johansen TE, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 2008;31:S68S78.